The following is from a release from Vioguard:
Bothell- based Vioguard Inc. announced that it has raised a $5 million Series A round of financing from Imagen Capital Partners. Vioguard is a UV-C technology solutions company.
This investment brings Vioguard’s total funding since launching its ultraviolet disinfection solutions to $11 million and will be used to expand its sales and marketing efforts, as well as, broaden and accelerate product development initiatives. With this investment, Imagen Capital Partners will designate two persons to join the Vioguard board of directors.
“I believe the investment by Imagen will help Vioguard advance our leadership position within the ultraviolet disinfection arena,” said Vioguard President and CEO Laurance Ranta. “We are pleased to welcome Imagen Capital Partners as a shareholder and look forward to an exciting and prosperous future with them.”
Vioguard personnel believes this investment will further enable it to develop its products and execute on its business strategy. Vioguard’s patented flagship product is a self-sanitizing automated keyboard and mouse system that uses high-powered germicidal ultraviolet light, known as UV-C. This system, which has been cleared by the U.S. Food and Drug Administration, effectively kills 99.99 percent of all bacteria, viruses, fungi, and drug-resistant pathogens that have been proven to be responsible for millions of Hospital-Acquired Infections (HAIs) worldwide.
“We are excited about Vioguard’s technology platform and its leadership team as they continue their efforts to bring pioneering UV-C solutions to the worldwide marketplace,” said Chris Barrow, managing director at Imagen Capital Partners.
Vioguard currently holds multiple patents in the UV space for sanitizing surfaces, such as computer keyboards, touchscreens, telephones, escalator handrails, writing implements, as well as various other surfaces and input devices. Additional product introductions are expected to include an escalator handrail sanitizer and a pen sterilizing device, both projected to be released across 2017.